Abstract
Abstract
In the current study, Fe3O4/Ag nanohybrids demonstrating high efficiency in liver cancer ferroptosis therapy and MR imaging were synthesized using a facile one-pot approach. Subsequently, their morphology, chemical composition, structure, Fenton reaction activity, and magnetic resonance (MR) contrast effect were systemically assessed. Importantly, the in vitro studies demonstrated that the Fe3O4/Ag nanohybrids had a high therapeutic efficiency in treating liver cancer cells and performed exceptionally well during T2-weight MR imaging. Correspondingly, these Fe3O4/Ag nanohybrids demonstrate significant potential for use in the field of biomedicine.
Reference24 articles.
1. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015;Global Burden of Disease Liver Cancer;JAMA oncology.,2017
2. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study;Global Burden of Disease Cancer;JAMA Oncology.,2019
3. Annual report to the nation on the status of cancer, I: National Cancer Statistics;Henley;Cancer.,2020
4. Ferroptosis: an iron-dependent form of nonapoptotic cell death;Dixon;Cell.,2012
5. Emerging strategies of cancer therapy based on ferroptosis;Shen;Adv. Mater.,2018